Active Pharmaceutical Ingredients

• 

  Supriya Lifescience Shares To List On Bourses Tomorrow

  Supriya Lifescience, manufacturer of active pharmaceutical ingredients' shares will list on the bourses tomorrow on Tuesday, December 28

• 

  Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump

  India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

• 

  India Bans Export Of Anti-Viral Drug Remdesivir Amid Surge In Covid Cases

  India has banned export of anti-viral drug Remdesivir amid a surge in Covid cases in the country. In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients till situation stabilises

• 

  Pharma Firm, India's Best-Performing Stock, Sees Wave of Optimistic Calls

  In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi's Laboratories -- one of the top producers of active pharmaceutical ingredients

• 

  India To Send Nearly 1,000 Tonnes Of Paracetamol Raw Material To Europe

  India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient (API) for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms.

• 

  Government Restricts Export Of Some Pharma Ingredients, Drugs

  Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

• 

  Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

  Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.

• 

  Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

  An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

• 

  Industry Body Calls For Reduction In GST On Active Pharmaceutical Ingredients

  Pharma formulations attract GST of 12 per cent whereas inputs active pharmaceutical ingredients (API) have GST of 18 per cent which has led to accumulation of Input tax Credit.

• 

  Wockhardt Shareholders Approve Raising Of Upto Rs 1,000 Crore

  Wockhardt has three research centres and 12 manufacturing plants, with businesses ranging from the making and marketing of pharmaceuticals, active pharmaceutical ingredients (APIs) and vaccines.

• 

  Third Party Consultants Helping In Remediation Process: Ipca Labs

  Last year, the USFDA had put the company's Ratlam-based active pharmaceutical ingredients(API) facility under import alert.

• 

  Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns

  The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.

• 

  Laurus Labs Makes Strong Market Debut, Shares Jump 16%

  Laurus Labs makes active pharmaceutical ingredients or APIs that go into the making a range of medicines, chiefly HIV/AIDS drugs.

• 

  Divi's Labs Gets 5 Observations From USFDA For Vizag Plant

  The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the manufacturing plant.

• 

  India's Trade Deficit With China Rises To $53 Billion In FY16

  Efforts are being made for revival of (Active Pharmaceutical Ingredient) API industry to lessen dependency on import of key starting materials, intermediates and bulk drugs including from China